Corcept Therapeutics (CORT) Interest Expenses (2010 - 2026)
Corcept Therapeutics (CORT) posted Interest Expenses of $11.1 million for Q2 2026, down 3.59% sequentially from $11.5 million in Q1 2026, and up 36.42% YoY from $8.1 million in Q2 2025.
Corcept Therapeutics (CORT) Interest Expenses (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Interest Expenses for 17 years, with the latest figure at $11.1 million in Q2 2026.
- Quarterly Interest Expenses rose 36.42% year-over-year to $11.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.1 million (up 36.42% YoY) and the FY2025 annual result came in at $20.9 million, up 19.85% from the prior year.
- Interest Expenses declined to $11.1 million in Q2 2026 per CORT's latest filing, from $11.5 million in the prior quarter.
- Over five years, Interest Expenses peaked at $17.5 million in Q4 2024 and troughed at $2000.0 in Q4 2025.
- A 5-year average of $7.8 million and a median of $8.4 million in 2022 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 1275.2% in 2025, down 99.99% in 2025.
- Over 5 years, Interest Expenses stood at $2.3 million in 2022, then advanced by 5.56% to $2.4 million in 2023, then soared by 630.24% to $17.5 million in 2024, then tumbled by 99.99% to $2000.0 in 2025, then soared by 553350.0% to $11.1 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $11.1 million, $11.5 million, and $2000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 11.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.07 Mn |
| Jun 30, 2026 | 11.07 Mn |
| Mar 31, 2026 | 11.48 Mn |
| Mar 31, 2026 | 11.48 Mn |
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 7.73 Mn |
| Sep 30, 2025 | 7.73 Mn |
| Jun 30, 2025 | 8.11 Mn |
| Jun 30, 2025 | 8.11 Mn |
| Mar 31, 2025 | 8.49 Mn |
| Mar 31, 2025 | 8.49 Mn |
| Dec 31, 2024 | 17.46 Mn |
| Dec 31, 2024 | 17.46 Mn |
| Sep 30, 2024 | 8.73 Mn |
| Sep 30, 2024 | 8.73 Mn |
| Jun 30, 2024 | 8.73 Mn |
| Jun 30, 2024 | 8.73 Mn |
| Mar 31, 2024 | 617,000.00 |
| Mar 31, 2024 | 617,000.00 |